News

In a study of 51,258 survivors weighted to represent a larger population of approximately 178.8 million people, 3.6 million survivors reported a functional limitation in 1999, and that number increased to 8.2 million in 2018.

New research has uncovered an unexpected link between two hallmarks of cancer: chromosomal instability and epigenetic alterations.

Not all cancer metastases have the same destructive effect. Researchers demonstrate different mechanisms in experiments.

Zirconium-based materials have been shown to effectively separate radium and actinium, which could enable the large-scale production of radioisotopes for cancer therapy.

Results of a large Phase 3 clinical trial reveal that a targeted cancer drug, osimertinib, cut the risk of death by 51% for patients following surgery to remove non-small cell lung cancers harboring a specific mutation.

Tumors of different types, stages and microscopic aggressiveness can have different outcomes in patients with the same presentation. Researchers have discovered that this may be due to differences in tumor mutation burden.

AI algorithms identify both missed breast cancers and tissue features may predict future cancers.

The U.S. biosimilar drug market emerged in 2015 to provide safe, effective and more affordable alternatives to existing biologic drugs, but it has been slow to develop compared with Europe.

Researchers have pinpointed a molecular chain reaction that helps breast cancer to metastasize, suggesting a way of preventing secondary tumors.

Researchers develop new way to grow and measure how tumor organoids respond to therapy.